Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: A Japanese nationwide randomized controlled trial

Toshiaki Watanabe, Yoichi Ajioka, Takayuki Matsumoto, Naoki Tomotsugu, Toru Takebayashi, Eisuke Inoue, Bunei Iizuka, Masahiro Igarashi, Yasushi Iwao, Kazuo Ohtsuka, Shin Ei Kudo, Kiyonori Kobayashi, Miwa Sada, Takayuki Matsumoto, Ichiro Hirata, Kazunari Murakami, Masakazu Nagahori, Kenji Watanabe, Nobuyuki Hida, Fumiaki UenoShinji Tanaka, Mamoru Watanabe, Toshifumi Hibi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Colorectal cancer is one of the complications of ulcerative colitis (UC) and the risk of cancer increases as the duration of the disease becomes longer. Surveillance colonoscopy has been considered to be important for the early detection and early treatment of colorectal cancer, especially in longstanding UC. Because it is not always easy to detect neoplastic lesions in UC endoscopically, guidelines recommend the use of step biopsy in surveillance, in which either 4 biopsy specimens for every 10 cm or a total of 33 or more biopsy specimens are obtained. However, it has been pointed out that a step biopsy obtaining several tens of biopsy specimens may not be an ideal method in terms of invasiveness to the patient or medical cost. Instead of step biopsy, recent studies report the usefulness of target biopsy, in which biopsy tissues are obtained only from regions suspected of neoplasia. Therefore, the Research Group for Intractable Inflammatory Bowel Disease of the Ministry of Health, Labour and Welfare of Japan has initiated a randomized controlled study to compare the efficacy of step biopsy and target biopsy. The present article gives an introduction to this ongoing randomized controlled trial in Japan.

Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalJournal of Gastroenterology
Volume46
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2011 Jan

Fingerprint

Ulcerative Colitis
Randomized Controlled Trials
Biopsy
Colorectal Neoplasms
Japan
Colonoscopy
Inflammatory Bowel Diseases
Neoplasms
Guidelines
Costs and Cost Analysis
Health

Keywords

  • Colonoscopy
  • Colorectal cancer
  • Dysplasia
  • Randomized controlled trial
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis : A Japanese nationwide randomized controlled trial. / Watanabe, Toshiaki; Ajioka, Yoichi; Matsumoto, Takayuki; Tomotsugu, Naoki; Takebayashi, Toru; Inoue, Eisuke; Iizuka, Bunei; Igarashi, Masahiro; Iwao, Yasushi; Ohtsuka, Kazuo; Kudo, Shin Ei; Kobayashi, Kiyonori; Sada, Miwa; Matsumoto, Takayuki; Hirata, Ichiro; Murakami, Kazunari; Nagahori, Masakazu; Watanabe, Kenji; Hida, Nobuyuki; Ueno, Fumiaki; Tanaka, Shinji; Watanabe, Mamoru; Hibi, Toshifumi.

In: Journal of Gastroenterology, Vol. 46, No. SUPPL. 1, 01.2011, p. 11-16.

Research output: Contribution to journalArticle

Watanabe, T, Ajioka, Y, Matsumoto, T, Tomotsugu, N, Takebayashi, T, Inoue, E, Iizuka, B, Igarashi, M, Iwao, Y, Ohtsuka, K, Kudo, SE, Kobayashi, K, Sada, M, Matsumoto, T, Hirata, I, Murakami, K, Nagahori, M, Watanabe, K, Hida, N, Ueno, F, Tanaka, S, Watanabe, M & Hibi, T 2011, 'Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: A Japanese nationwide randomized controlled trial', Journal of Gastroenterology, vol. 46, no. SUPPL. 1, pp. 11-16. https://doi.org/10.1007/s00535-010-0327-0
Watanabe, Toshiaki ; Ajioka, Yoichi ; Matsumoto, Takayuki ; Tomotsugu, Naoki ; Takebayashi, Toru ; Inoue, Eisuke ; Iizuka, Bunei ; Igarashi, Masahiro ; Iwao, Yasushi ; Ohtsuka, Kazuo ; Kudo, Shin Ei ; Kobayashi, Kiyonori ; Sada, Miwa ; Matsumoto, Takayuki ; Hirata, Ichiro ; Murakami, Kazunari ; Nagahori, Masakazu ; Watanabe, Kenji ; Hida, Nobuyuki ; Ueno, Fumiaki ; Tanaka, Shinji ; Watanabe, Mamoru ; Hibi, Toshifumi. / Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis : A Japanese nationwide randomized controlled trial. In: Journal of Gastroenterology. 2011 ; Vol. 46, No. SUPPL. 1. pp. 11-16.
@article{e24025e95a704d6da95ccbefcfcdb5a2,
title = "Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: A Japanese nationwide randomized controlled trial",
abstract = "Colorectal cancer is one of the complications of ulcerative colitis (UC) and the risk of cancer increases as the duration of the disease becomes longer. Surveillance colonoscopy has been considered to be important for the early detection and early treatment of colorectal cancer, especially in longstanding UC. Because it is not always easy to detect neoplastic lesions in UC endoscopically, guidelines recommend the use of step biopsy in surveillance, in which either 4 biopsy specimens for every 10 cm or a total of 33 or more biopsy specimens are obtained. However, it has been pointed out that a step biopsy obtaining several tens of biopsy specimens may not be an ideal method in terms of invasiveness to the patient or medical cost. Instead of step biopsy, recent studies report the usefulness of target biopsy, in which biopsy tissues are obtained only from regions suspected of neoplasia. Therefore, the Research Group for Intractable Inflammatory Bowel Disease of the Ministry of Health, Labour and Welfare of Japan has initiated a randomized controlled study to compare the efficacy of step biopsy and target biopsy. The present article gives an introduction to this ongoing randomized controlled trial in Japan.",
keywords = "Colonoscopy, Colorectal cancer, Dysplasia, Randomized controlled trial, Ulcerative colitis",
author = "Toshiaki Watanabe and Yoichi Ajioka and Takayuki Matsumoto and Naoki Tomotsugu and Toru Takebayashi and Eisuke Inoue and Bunei Iizuka and Masahiro Igarashi and Yasushi Iwao and Kazuo Ohtsuka and Kudo, {Shin Ei} and Kiyonori Kobayashi and Miwa Sada and Takayuki Matsumoto and Ichiro Hirata and Kazunari Murakami and Masakazu Nagahori and Kenji Watanabe and Nobuyuki Hida and Fumiaki Ueno and Shinji Tanaka and Mamoru Watanabe and Toshifumi Hibi",
year = "2011",
month = "1",
doi = "10.1007/s00535-010-0327-0",
language = "English",
volume = "46",
pages = "11--16",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis

T2 - A Japanese nationwide randomized controlled trial

AU - Watanabe, Toshiaki

AU - Ajioka, Yoichi

AU - Matsumoto, Takayuki

AU - Tomotsugu, Naoki

AU - Takebayashi, Toru

AU - Inoue, Eisuke

AU - Iizuka, Bunei

AU - Igarashi, Masahiro

AU - Iwao, Yasushi

AU - Ohtsuka, Kazuo

AU - Kudo, Shin Ei

AU - Kobayashi, Kiyonori

AU - Sada, Miwa

AU - Matsumoto, Takayuki

AU - Hirata, Ichiro

AU - Murakami, Kazunari

AU - Nagahori, Masakazu

AU - Watanabe, Kenji

AU - Hida, Nobuyuki

AU - Ueno, Fumiaki

AU - Tanaka, Shinji

AU - Watanabe, Mamoru

AU - Hibi, Toshifumi

PY - 2011/1

Y1 - 2011/1

N2 - Colorectal cancer is one of the complications of ulcerative colitis (UC) and the risk of cancer increases as the duration of the disease becomes longer. Surveillance colonoscopy has been considered to be important for the early detection and early treatment of colorectal cancer, especially in longstanding UC. Because it is not always easy to detect neoplastic lesions in UC endoscopically, guidelines recommend the use of step biopsy in surveillance, in which either 4 biopsy specimens for every 10 cm or a total of 33 or more biopsy specimens are obtained. However, it has been pointed out that a step biopsy obtaining several tens of biopsy specimens may not be an ideal method in terms of invasiveness to the patient or medical cost. Instead of step biopsy, recent studies report the usefulness of target biopsy, in which biopsy tissues are obtained only from regions suspected of neoplasia. Therefore, the Research Group for Intractable Inflammatory Bowel Disease of the Ministry of Health, Labour and Welfare of Japan has initiated a randomized controlled study to compare the efficacy of step biopsy and target biopsy. The present article gives an introduction to this ongoing randomized controlled trial in Japan.

AB - Colorectal cancer is one of the complications of ulcerative colitis (UC) and the risk of cancer increases as the duration of the disease becomes longer. Surveillance colonoscopy has been considered to be important for the early detection and early treatment of colorectal cancer, especially in longstanding UC. Because it is not always easy to detect neoplastic lesions in UC endoscopically, guidelines recommend the use of step biopsy in surveillance, in which either 4 biopsy specimens for every 10 cm or a total of 33 or more biopsy specimens are obtained. However, it has been pointed out that a step biopsy obtaining several tens of biopsy specimens may not be an ideal method in terms of invasiveness to the patient or medical cost. Instead of step biopsy, recent studies report the usefulness of target biopsy, in which biopsy tissues are obtained only from regions suspected of neoplasia. Therefore, the Research Group for Intractable Inflammatory Bowel Disease of the Ministry of Health, Labour and Welfare of Japan has initiated a randomized controlled study to compare the efficacy of step biopsy and target biopsy. The present article gives an introduction to this ongoing randomized controlled trial in Japan.

KW - Colonoscopy

KW - Colorectal cancer

KW - Dysplasia

KW - Randomized controlled trial

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=78651376542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651376542&partnerID=8YFLogxK

U2 - 10.1007/s00535-010-0327-0

DO - 10.1007/s00535-010-0327-0

M3 - Article

C2 - 21038106

AN - SCOPUS:78651376542

VL - 46

SP - 11

EP - 16

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - SUPPL. 1

ER -